PubMed Health⌕ Search

PubMed · 2490957

Research needs in quality assurance.

Abstract

Originally written as a background paper for the discussion on the research needs in quality assurance by the WHO's global Advisory Committee on Health Research, this paper has two sections. The main section introduces key political, organizational and methodological issues. Special attention is being paid to unsolved problems and controversies to whose resolution research could contribute. The main issues and research needs relate to the concept of quality; conflicting expectations and objectives of the concerned parties; the need to broaden the scope of quality assurance from the science of medicine to art of medicine, from the process of care to the outcome of care, and from exclusively professional concerns to patient satisfaction; relationship between quality assurance and such related concepts as technology assessment and risk management; development of measurement methods; choice of proper subject of quality assurance; and setting criteria and standards of good quality. In addition, research into the epidemiology of quality, introduction and organization of quality assurance and correction of observed defects is needed. Quality assurance itself also needs to be evaluated.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Vuori. 1989. Research needs in quality assurance.. https://doi.org/10.1093/intqhc%2F1.2-3.147

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Recurrence risk to offspring in extended multiplex schizophrenia pedigrees from a Pacific Island isolate.

Genetic transmission plays a major role in the pathogenesis of schizophrenia. Family, twin, and adoption studies have consistently shown that risks in relatives are many times greater than the general population risk of approximately 1%. McGue, Gottesman, and Rao (1983; Am J Hum Genet 35:1161-1178) calculated risk estimates of 12.8% for offspring and 3.5% for nieces/nephews of schizophrenia patients based on a large data set of Western European families. The present study evaluated corresponding risk levels in Palau, an isolated population in Micronesia where the prevalence of narrowly (broadly) defined schizophrenia is 1.99% (2.67%) and cases cluster in extended pedigrees, 20 of which contain 80% of affected individuals. We hypothesized that offspring in these extended families would have a higher risk for schizophrenia than offspring in smaller schizophrenia pedigrees from more genetically heterogeneous populations. RDC diagnostic data based on complete ascertainment of cases and their families covering the past two generations were used to quantify empirical recurrence risks in the offspring and nieces/nephews of Palauan schizophrenia patients. Risks to 1st- and 2nd-degree offspring were approximately double the rates found in the smaller Western European families: 23.4% in the offspring of an affected parent, 6.4% in offspring with one affected aunt/uncle, and 15.0% in offspring with two or more affected aunts/uncles. Recurrence rates in offspring of an affected parent were 1.6 times higher in males (27.9%) than in females (17.7%). The high risk levels we found in Palauan offspring reflect the elevated population prevalence, strong familial aggregation, and multi-lineal transmission pattern of schizophrenia in Palau.

Europe↗